Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
787.04
+7.37 (0.95%)
At close: Feb 23, 2026, 4:00 PM EST
789.00
+1.96 (0.25%)
After-hours: Feb 23, 2026, 7:46 PM EST
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$812.57
Upside
+3.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $865 → $975 | Strong Buy | Maintains | $865 → $975 | +23.88% | Feb 9, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $850 → $950 | Buy | Maintains | $850 → $950 | +20.71% | Feb 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $750 → $865 | Buy | Reiterates | $750 → $865 | +9.91% | Feb 2, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $768 → $769 | Hold | Maintains | $768 → $769 | -2.29% | Feb 2, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $745 → $800 | Hold | Maintains | $745 → $800 | +1.65% | Feb 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $740 → $800 | Buy | Maintains | $740 → $800 | +1.65% | Feb 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $820 → $818 | Strong Buy | Maintains | $820 → $818 | +3.93% | Feb 2, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $750 → $875 | Buy | Maintains | $750 → $875 | +11.18% | Jan 22, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $798 → $820 | Strong Buy | Maintains | $798 → $820 | +4.19% | Jan 8, 2026 |
| B of A Securities | B of A Securities | Sell → Strong Buy Upgrades $627 → $860 | Sell → Strong Buy | Upgrades | $627 → $860 | +9.27% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $767 → $768 | Hold | Maintains | $767 → $768 | -2.42% | Dec 12, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $700 → $745 | Hold | Maintains | $700 → $745 | -5.34% | Dec 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $850 → $1,057 | Strong Buy | Maintains | $850 → $1,057 | +34.30% | Dec 4, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $725 → $850 | Buy | Maintains | $725 → $850 | +8.00% | Dec 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $767 | Buy → Hold | Downgrades | $767 | -2.55% | Dec 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $812 → $798 | Strong Buy | Initiates | $812 → $798 | +1.39% | Nov 24, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.